VRME Form 4: 35,000-share transfer, 35,000 restricted grant, convertible note details
Rhea-AI Filing Summary
VerifyMe, Inc. (VRME) director Marshall S. Geller reported multiple equity transactions and holdings. On 09/19/2025 the reporting person transferred 35,000 common shares to a family trust for which he is trustee, reducing his direct holdings to 52,000 shares. The report shows an indirect holding of 473,344 shares held by the Marshall & Patricia Geller Living Trust, which includes 68,310 vested restricted stock units payable upon separation from board service. On 10/09/2025 the reporting person was granted 35,000 restricted shares under the 2020 Equity Incentive Plan that generally vest on the first anniversary of the grant. Derivative holdings held indirectly by the trust include a warrant for 31,104 shares (exercise price $3.215, expires 10/14/2027) and an 8% convertible promissory note convertible into 152,174 shares at $1.15 due 08/25/2026 with principal $175,000.
Positive
- None.
Negative
- None.
Insights
Director shifted shares into a family trust and received new restricted stock that vests over one year.
The transfer of 35,000 shares into a family trust on 09/19/2025 is a non-sale reallocation of beneficial ownership and does not change aggregate economic exposure when combined with indirect holdings of 473,344 shares.
The additional grant of 35,000 restricted shares under the 2020 Equity Incentive Plan on 10/09/2025 vesting in one year aligns director compensation with retention. Watch near-term vesting events and any future transfers that could alter voting or saleable float within the next 12 months.
Total reported indirect and direct holdings create concentrated insider exposure, supported by convertible debt and warrants.
Combined direct and indirect common stock and instruments imply substantial potential dilution from 152,174 convertible-note shares and 31,104 warrant shares. The convertible note has an 8% coupon and conversion price $1.15, maturing on 08/25/2026.
Monitor the conversion timeline and warrant exercise window to assess dilution and cash obligations over the next 9 months to 11 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 | 35,000 | $0.00 | -- |
| Gift | Common Stock, par value $0.001 | 35,000 | $0.00 | -- |
| holding | Warrant (Right to Buy) | -- | -- | -- |
| holding | 8% Convertible Promissory Note due 2026 | -- | -- | -- |
| holding | Common Stock, par value $0.001 | -- | -- | -- |
Footnotes (1)
- On September 19, 2025, the Reporting Person transferred 35,000 shares to a family trust of which the Reporting Person is trustee. Includes 68,310 vested restricted stock units that become payable, on a one-for-one basis, in shares of common stock of VerifyMe, Inc. upon separation of the reporting person's service as a director. This restricted stock award was granted under the VerifyMe, Inc. 2020 Equity Incentive Plan and, except as otherwise provided in the award notice, vests on the first anniversary of the grant date.
